Akorn, Inc. (NASDAQ:AKRX)
CAPS Rating:
The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
Recs
P/b = 10.2
P/S = 12.7
No earnings
Margins are worse with increasing inventory.
Price change over 106%